在心力衰竭中冠状动脉微血管疾病
Payel Sen1,2,3, Lili Wang1,2, Laura d'Ambrosio1,2,3
1Institute for Surgical Research, Walter Brendel Center of Experimental Medicine, University Clinic Munich, Munich, Germany.
Physiological reports
|August 20, 2025
概括
由于共同的风险因素,心力衰竭与保存的喷射分数 (HFpEF) 和冠状动脉微血管疾病 (CMD) 经常并存. 了解这些联系可以改善两种疾病的治疗方法.
科学领域:
- 心脏病学
- 内部医学
- 血管生物学
背景情况:
- 由于老化和生活方式因素,如糖尿病和高血压,心力衰竭的患病率正在上升.
- 冠状动脉微血管疾病 (CMD) 经常与HFpEF并存,使患者的预后恶化.
- 患有HFpEF患者往往有多种并发症,增加了疾病的复杂性.
研究的目的:
- 审查关于CMD和HFpEF重叠的流行病学数据.
- 确定共享的生物标志物和病理生理路径.
- 讨论针对CMD和HFpEF的心脏代谢干预措施.
主要方法:
- 文献审查和流行病学证据的综合.
- 对HFpEF和CMD共享的病理生理机制的分析.
- 评估当前和新兴的治疗策略.
主要成果:
- 由于共同的风险因素和双向信号传递,HFpEF和CMD之间存在显著的病理生理重叠.
- 不同的HFpEF患者群体显示出独特的并发症模式和预后.
- 既有和新的治疗方法针对这两种疾病的共享机制.
结论:
- 心脏代谢干预有望同时解决HFpEF和CMD问题.
- 更深入地了解相互关联的途径对于开发新疗法至关重要.
- 精确的患者管理策略可以减轻同时出现的HFpEF和CMD的负担.
相关概念视频
Heart Failure II: Pathophysiology
38
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
38
Pathophysiology of Heart Failure
1.8K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.8K
Coronary Artery Disease II: Pathophysiology
34
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
34
Heart Failure I: Introduction
54
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
54
Coronary Artery Disease I: Introduction
55
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
55
Coronary Artery Disease III: Clinical Manifestations
32
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
32


